CN111518753A - Application of insulin-like growth factor 2 in promoting differentiation of human skin fibroblasts into adipocytes - Google Patents
Application of insulin-like growth factor 2 in promoting differentiation of human skin fibroblasts into adipocytes Download PDFInfo
- Publication number
- CN111518753A CN111518753A CN202010266819.8A CN202010266819A CN111518753A CN 111518753 A CN111518753 A CN 111518753A CN 202010266819 A CN202010266819 A CN 202010266819A CN 111518753 A CN111518753 A CN 111518753A
- Authority
- CN
- China
- Prior art keywords
- culture medium
- insulin
- differentiation
- days
- human skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1307—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2523/00—Culture process characterised by temperature
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention provides an application of insulin-like growth factor 2 in promoting human skin fibroblasts to differentiate into adipocytes, which is to pre-treat human skin fibroblasts with insulin-like growth factor 2 with a final concentration of 50-200ng/ml before the human skin fibroblasts are subjected to in vitro induced differentiation. On the basis of the original 6+2+8 induced differentiation mode, the invention obviously improves the efficiency of differentiating human skin fibroblasts into adipocytes by the pretreatment of the insulin-like growth factor 2. The method can efficiently induce and differentiate human skin fibroblasts into adipocytes, and provides a new thought and a new method for clinical skin wound healing, scar repair and treatment of lipodystrophy.
Description
Technical Field
The invention relates to the technical field of biology, in particular to application of insulin-like growth factor 2 in promoting human skin fibroblasts to differentiate into adipocytes.
Background
CN201910876049.6 discloses a method for inducing human skin fibroblasts to differentiate into adipocytes in vitro, which has relatively low efficiency of differentiating human skin fibroblasts into adipocytes, and is difficult to be widely used in clinical applications such as wound repair, scar repair, and lipodystrophy treatment.
Disclosure of Invention
The invention aims to provide application of insulin-like growth factor 2 in promoting differentiation of human skin fibroblasts into adipocytes.
Another object of the present invention is to provide a method for efficiently inducing the differentiation of human skin fibroblasts into adipocytes in vitro.
To achieve the object of the present invention, in a first aspect, the present invention provides the use of insulin-like growth factor 2 for promoting the differentiation of human skin fibroblasts into adipocytes.
The application comprises the following steps: human skin fibroblasts are pre-treated with insulin-like growth factor 2 at a final concentration of 50-200ng/ml (preferably 50ng/ml, 100ng/ml or 200ng/ml) prior to in vitro induced differentiation.
In a second aspect, the present invention provides a method for inducing human skin fibroblasts to differentiate into adipocytes in vitro, comprising culturing human skin fibroblasts in vitro in a basal medium until the confluency of the cells reaches 50-70%, adding insulin-like growth factor 2 at a final concentration of 50-200ng/ml (preferably 50ng/ml, 100ng/ml or 200ng/ml), pretreating the cells for 12-48 hours (preferably 24 hours), and then inducing differentiation;
the step of inducing differentiation comprises: changing the culture medium into an induced differentiation culture medium I, culturing for 6-10 days, and changing the culture medium every two days; then, replacing the induced differentiation culture medium I with an induced differentiation culture medium II, and culturing for 2-4 days; finally, changing the induced differentiation culture medium to a basic culture medium, culturing for 8-14 days, and changing the culture medium once every two days;
wherein the basic culture medium is a high-glucose DMEM culture medium containing 10-20% fetal calf serum, 100U/mL penicillin and 100 mu g/mL streptomycin;
the induced differentiation culture medium I is a basic culture medium containing 0.5-1 mu M dexamethasone, 10-20 mu g/mL insulin, 1-2 mu M rosiglitazone and 0.2-0.5mM 1-methyl-3-isobutyl xanthine;
the induction differentiation culture medium (II) is a basal culture medium containing 10-20 mug/mL of insulin.
Preferably, the basal medium is a high-glucose DMEM medium containing 20% fetal bovine serum, 100U/mL penicillin and 100. mu.g/mL streptomycin.
Preferably, the differentiation induction medium (i) is a basal medium containing 1. mu.M dexamethasone, 20. mu.g/mL insulin, 2. mu.M rosiglitazone and 0.5mM 1-methyl-3-isobutylxanthine.
Preferably, the differentiation induction medium (c) is a basal medium containing 20. mu.g/mL of insulin.
The culture medium is preferably prepared at present, so as to avoid degradation of effective components of the medicine.
In one embodiment of the present invention, a method for inducing human skin fibroblasts to differentiate into adipocytes in vitro comprises: culturing human skin fibroblasts in vitro in a basal medium until the cell confluence reaches 50-70% (preferably 50ng/ml, 100ng/ml or 200ng/ml, more preferably 200ng/ml) and transferring to less than 10 generations (preferably 2-7 generations, more preferably 7 generations), adding insulin-like growth factor 2 with a final concentration of 50-200ng/ml (preferably 50ng/ml, 100ng/ml or 200ng/ml), and pretreating the cells for 24 hours; then, the culture medium is changed into an induced differentiation culture medium I, and the culture is carried out for 6 days, and the liquid is changed every two days; then, the induced differentiation medium I is replaced by an induced differentiation medium II, and the culture is carried out for 2 days; finally, changing the induced differentiation culture medium to a basic culture medium, culturing for 8 days, and changing the culture medium once every two days;
wherein the basic culture medium is a high-glucose DMEM culture medium containing 20% fetal calf serum, 100U/mL penicillin and 100 mu g/mL streptomycin;
the induced differentiation culture medium I is a basic culture medium containing 1 mu M dexamethasone, 20 mu g/mL insulin, 2 mu M rosiglitazone and 0.5mM 1-methyl-3-isobutyl xanthine;
the induction differentiation culture medium is a basal culture medium containing 20 mu g/mL insulin.
In the present invention, the cell culture conditions are: 35-37 ℃ and 5% CO2Preferably 37 ℃ and 5% CO2。
In a third aspect, the present invention provides adipocytes prepared in accordance with the above-described methods.
In a fourth aspect, the invention provides any one of the following uses of the adipocytes:
(1) used for preparing biomedical materials and tissue repair materials;
(2) for wound repair and scar repair;
(3) can be used for treating lipodystrophy.
The cell source used in the invention is primary human skin fibroblast (HDF), and the material taking and the separation are convenient. The cell isolation method is as follows: first, from volunteersRemoving skin tissue with diameter of 1mm from skin, and washing with Phosphate Buffered Saline (PBS) for 3 times; then, excess adipose tissues were removed with an ophthalmic scissors in a clean bench, and the remaining tissues were minced and washed 3 times with PBS; then, 1-2mL of pancreatin 0.25% was added to immerse all tissue pieces in a solution containing 5% CO2Digesting for 5-10min at 37 ℃ in the cell culture box; after digestion was complete, 1mL of basal medium was added to stop digestion. Then, the pipette gun is used to blow and suck the cell clusters gently and repeatedly. Finally, the cell suspensions were transferred to 35mm petri dishes, 4mL of basal medium was added, and the mixture was placed in a cell incubator under 5% CO2Culturing at 37 deg.C for 4-6 days. During the culture process, the culture medium can be supplemented appropriately according to the amount of the culture medium in the culture dish. Finally, the isolated cells were primary human dermal fibroblasts. After the cells are full, subculture is carried out. In the whole cell separation process, aseptic operation is ensured, and pollution is avoided. After the cells are separated, mycoplasma detection is carried out, and the cells can be used for subsequent experiments after the cells are determined to be free from mycoplasma pollution. Through multiple induced differentiation experiments, the generation number of HDF cells for inducing differentiation is not too high, and is preferably within 10 generations; HDF cells over 10 generations induce differentiation less efficiently, and the higher the generation number, the harder the induction of differentiation, and the lower the differentiation efficiency. Therefore, HDF cells having a low number of generations should be cryopreserved as much as possible in order to facilitate the subsequent induced differentiation experiment.
And (3) inducing a differentiation scheme: the whole process of inducing and differentiating HDF cells mainly comprises two parts of pretreatment and induced differentiation. First, insulin-like growth factor 2(IGF2) pretreatment was performed for 24 hours when the HDF cells reached 50-70% confluence. Then, induced differentiation is carried out according to a differentiation mode of '6 +2+ 8-16 days', namely, a first induced differentiation medium is induced for 6 days, a second induced differentiation medium is induced for 2 days, and a basic medium is continuously cultured for 8 days. The mode of 'firstly pretreating with insulin-like growth factor 2 and then inducing differentiation' greatly improves the efficiency of differentiating human skin fibroblasts into adipocytes.
By the technical scheme, the invention at least has the following advantages and beneficial effects:
on the basis of the original 6+2+8 induced differentiation mode, the invention obviously improves the efficiency of differentiating human skin fibroblasts into adipocytes by the pretreatment of the insulin-like growth factor 2. Taking 100ng/ml of insulin-like growth factor 2 as an example, human skin fibroblasts are pretreated for 24 hours, then induced differentiation is carried out, the number of the finally obtained fat cells is 3 times of that of a control group (not pretreated by the insulin-like growth factor 2), and the expression of fat cell marker genes is improved to 3 times of that of the control group. The method can efficiently induce and differentiate human skin fibroblasts into adipocytes, and provides a new thought and a new method for clinical skin wound healing, scar repair and treatment of lipodystrophy.
Drawings
FIG. 1 shows the results of oil red staining induced by differentiation of human dermal fibroblasts into adipocytes in example 1 of the present invention.
FIG. 2 is the statistical result of the oil red staining induced by the differentiation of human dermal fibroblasts into adipocytes in example 1 of this invention.
FIG. 3 shows the results of detecting marker genes of adipocytes obtained by induced differentiation in example 1 of the present invention.
FIG. 4 shows the results of oil red staining induced by differentiation of human dermal fibroblasts into adipocytes in example 2 of this invention.
FIG. 5 shows the statistical results of the oil red staining induced by differentiation of human dermal fibroblasts into adipocytes in example 2 of the present invention.
FIG. 6 shows the results of detecting marker genes of adipocytes obtained by induced differentiation in example 2 of the present invention.
FIG. 7 shows the results of oil red staining induced by differentiation of human dermal fibroblasts into adipocytes in example 3 of this invention.
FIG. 8 shows the statistical results of the oil red staining induced by the differentiation of human dermal fibroblasts into adipocytes in example 3 of this invention.
FIG. 9 shows the results of detecting marker genes of adipocytes obtained by induced differentiation in example 3 of the present invention.
In fig. 2-3, 5-6, 8-9, P <0.01, P <0.001, P <0.0001, and the differences between the different treatment groups were statistically significant.
Detailed Description
The invention provides a method for efficiently inducing human skin fibroblasts to differentiate into adipocytes in vitro. The method comprises the following steps:
1. taking out the cover glass soaked in 75% alcohol, burning and sterilizing on an alcohol lamp, and then paving in 35mm culture dishes, wherein 4 cover glass are paved on each culture dish;
2. adding 4ml of basic culture medium into the culture dish, and spreading the overlapped cover glass with forceps for later cell passage;
3. after the primary HDF cells in the 10cm culture dish were overgrown, the culture medium in the culture dish was aspirated off, washed 2 times with 2ml of Phosphate Buffered Saline (PBS) each time; then sucking off PBS, adding 1ml of pancreatin with the concentration of 0.25%, and repeatedly shaking the culture dish by two hands to enable the pancreatin to uniformly infiltrate the bottom of the culture dish; finally placing in a container containing 5% CO2Digesting for 1-2min at 37 ℃ in the cell culture box;
4. the digested cells were removed and 0.5ml basal medium was added to the culture dish to stop the digestion; then repeatedly blowing and sucking by using a pipettor, uniformly blowing and transferring the cells into a 1.5ml centrifuge tube, and centrifuging for 4 minutes at 1000 rpm/min;
5. sucking off the supernatant, adding 1ml of a basal medium, slightly and repeatedly sucking, and uniformly mixing the cells; then, according to the following steps of 1: 4, evenly dividing the cell suspension into 4 35mm culture dishes paved with cover glass, repeatedly shaking the culture dishes by two hands to uniformly mix the cells, and then putting the cells in a cell culture box for culture;
6. after the confluence degree of the cells reaches 50-70%, adding insulin-like growth factor 2 with the final concentration of 50-200ng/ml, and pretreating the cells for 24 hours;
7. sucking off the basic culture medium, adding 3ml of induced differentiation culture medium I, putting the culture medium back into the cell culture box for continuous induced culture for 6 days, and replacing the fresh culture medium every two days; when the culture medium is replaced, the culture medium is gently added along the wall of the culture dish;
8. absorbing the induced differentiation culture medium I, adding 3ml of induced differentiation culture medium II, and carrying out induced culture for 2 days; as the induced differentiation proceeded, a shiny circular fat drop was found in the cells under a 10-fold microscope;
9. absorbing the induced differentiation culture medium II, adding 3ml of basal culture medium, continuing to culture for 8 days, and replacing the fresh culture medium every two days; under a microscope, cells containing fat drops are more and more, and fat drops in the cells are larger and larger;
10. after the induction differentiation is finished, taking out the cover glass in the culture dish for oil red staining, and detecting the induction differentiation effect; in addition, RNA of the residual cells of the culture dish is extracted, fluorescent quantitative PCR is carried out, the expression of marker genes Adiponectin, Fabp4 and Leptin of the mature adipocytes is detected, and the induced differentiation result is further verified.
Detection of induced differentiation results:
oil red dyeing
Oil red O is a very strong fat solvent and dye agent, capable of binding triglycerides and is therefore frequently used for fat dyeing. We performed oil red staining on cells after induced differentiation to detect fat droplets within mature adipocytes.
The specific operation is as follows:
1) the coverslip was washed 3 times with PBS and then fixed with 4% Paraformaldehyde (PFA) for 20 minutes;
2) after 3 washes with PBS, equilibrate with 60% isopropanol for 5 minutes;
3) hermetically dyeing with oil red O (dissolved in 60% isopropanol) at a concentration of 3g/L for 10 minutes;
4) washing with 60% isopropanol for 3 times;
5) staining with hematoxylin for 2 minutes;
6) washing with PBS for 3 times, air drying, and sealing to form image;
7) and counting the number of cells which are positively stained by oil red.
Detection of mature adipocyte marker gene
Adipoectin, Fabp4, and Leptin are marker genes for mature adipocytes, and are often used to measure the effect of adipocyte differentiation induction. Trizol is used for extracting total RNA from cells after induced differentiation, and after reverse transcription, fluorescent quantitative PCR is carried out to detect the expression levels of three genes, namely Adiponectin, Fabp4 and Leptin.
The PCR primer sequences used were as follows:
Adiponectin:5’-GATGGCAGAGATGGCAC-3’
5’-GCTGAGCGGTATACATAGG-3’
Fabp4:5’-ACGAGAGGATGATAAACTGGTGG-3’
5’-GCGAACTTCAGTCCAGGTCAAC-3’
Leptin:5’-CACCAAAACCCTCATCAAGACA-3’
5’-CTTTCTGTTTGGAGGAGACTGACT-3’
the following examples are intended to illustrate the invention but are not intended to limit the scope of the invention. Unless otherwise indicated, the examples follow conventional experimental conditions, such as the Molecular Cloning handbook, Sambrook et al (Sambrook J & Russell DW, Molecular Cloning: a Laboratory Manual,2001), or the conditions as recommended by the manufacturer's instructions.
The media used in the examples below:
the basal medium was high-glucose DMEM medium containing 20% fetal bovine serum, 100U/mL penicillin and 100. mu.g/mL streptomycin.
The induced differentiation culture medium (I) is a basic culture medium containing 1 mu M dexamethasone, 20 mu g/mL insulin, 2 mu M rosiglitazone and 0.5mM 1-methyl-3-isobutyl xanthine.
The induction differentiation culture medium is a basal culture medium containing 20 mu g/mL insulin.
High-glucose DMEM medium was purchased from Gibco.
Example 1 method for inducing differentiation of human skin fibroblasts into adipocytes with high efficiency in vitro
This example illustrates the results of induced differentiation using 50ng/ml insulin-like growth factor 2(IGF2) pre-treatment for 24 hours.
The induced differentiation method is as follows:
1. the isolated primary HDF cells were passaged to 35mm coverslippedAdding 3ml of basic culture medium into a culture dish, and placing the culture dish in a culture dish containing 5% CO2Culturing at 37 ℃ in the cell culture box;
2. after the confluence degree of the cells reaches 50-70%, adding insulin-like growth factor 2 with the final concentration of 50ng/ml, and pretreating the cells for 24 hours;
3. sucking off the basic culture medium, adding an induced differentiation culture medium I, continuously carrying out induced culture for 6 days, and replacing a fresh culture medium every two days;
4. absorbing the induced differentiation culture medium I, adding the induced differentiation culture medium II, and carrying out induced culture for 2 days;
5. absorbing the induced differentiation culture medium, adding a basic culture medium, continuously culturing for 8 days, and replacing the fresh culture medium every two days.
After induction differentiation is finished, the result of induction differentiation is detected through oil red staining and mature fat cell marker gene detection. The results are as follows:
oil red dyeing result
As shown in fig. 1, the red part is stained fat, and the non-induced HDF cells have no fat accumulation, while the HDF cells induced to differentiate for 16 days have significant fat accumulation. Compared with a control group (without IGF2 pretreatment), the induction of 50ng/ml IGF2 after 24 hours of pretreatment can obviously promote the differentiation of the fat cells.
② statistical result of oil red dyeing
As shown in FIG. 2, the number of cells showing positive staining for oil red in the non-induced HDF cells was 0, and the number of cells showing positive staining for oil red in the HDF cells induced to differentiate for 16 days were: control group 120/cm250ng/ml IGF2 pretreatment group 240/cm2。
③ detection of mature adipocyte marker gene
As shown in FIG. 3, by quantitative PCR (quantitative PCR), marker genes of three mature adipocytes, i.e., Adiponectin, Fabp4, and Leptin, were detected. The expression of the three marker genes of the 50ng/ml IGF2 pretreatment group is obviously higher than that of the control group.
Example 2 method for inducing differentiation of human skin fibroblasts into adipocytes with high efficiency in vitro
This example illustrates the results of induced differentiation using 100ng/ml insulin-like growth factor 2(IGF2) pre-treatment for 24 hours.
The method for inducing differentiation was the same as in example 1, but the "6 +2+ 8" mode for inducing differentiation was also used. Except that the pretreatment was changed to 100ng/ml insulin-like growth factor 2 for 24 hours.
After induction differentiation is finished, the result of induction differentiation is detected through oil red staining and mature fat cell marker gene detection. The results are as follows:
oil red dyeing result
As shown in fig. 4, the red part is stained fat, and the non-induced HDF cells have no fat accumulation, while the HDF cells induced to differentiate for 16 days have significant fat accumulation. Compared with a control group (without IGF2 pretreatment), 100ng/ml IGF2 can obviously promote adipocyte differentiation after being subjected to induction after 24 hours of pretreatment.
② statistical result of oil red dyeing
As shown in FIG. 5, the number of cells showing positive staining for magenta in the non-induced HDF cells was 0, and the number of cells showing positive staining for magenta in the HDF cells induced to differentiate for 16 days were: 130 pieces/cm in the control group2100ng/ml IGF2 pretreatment group 400/cm2。
③ detection of mature adipocyte marker gene
As shown in FIG. 6, by quantitative PCR (quantitative PCR), marker genes of three mature adipocytes, i.e., Adiponectin, Fabp4, and Leptin, were detected. The expression of three marker genes of the 100ng/ml IGF2 pretreatment group is obviously higher than that of the control group.
Example 3 method for inducing human skin fibroblasts to differentiate into adipocytes with high efficiency in vitro
This example illustrates the results of induced differentiation using 200ng/ml insulin-like growth factor 2(IGF2) pre-treatment for 24 hours.
The method for inducing differentiation was the same as in example 1, but the "6 +2+ 8" mode for inducing differentiation was also used. Except that the pretreatment was changed to 200ng/ml insulin-like growth factor 2 for 24 hours.
After induction differentiation is finished, the result of induction differentiation is detected through oil red staining and mature fat cell marker gene detection. The results are as follows:
oil red dyeing result
As shown in fig. 7, the red portion is stained fat, and the non-induced HDF cells did not accumulate fat, whereas the HDF cells induced to differentiate for 16 days had significant fat accumulation. And compared with a control group (without IGF2 pretreatment), the induction of 200ng/ml IGF2 after 24 hours of pretreatment can obviously promote the differentiation of the fat cells.
② statistical result of oil red dyeing
As shown in FIG. 8, the number of cells showing positive staining for magenta in the non-induced HDF cells was 0, and the number of cells showing positive staining for magenta in the HDF cells induced to differentiate for 16 days were: control group 123/cm2200ng/ml IGF2 pretreatment group 512/cm2。
③ detection of mature adipocyte marker gene
As shown in FIG. 9, by quantitative PCR (quantitative PCR), marker genes of three mature adipocytes, i.e., Adiponectin, Fabp4, and Leptin, were detected. The expression of three marker genes of 200ng/ml IGF2 pretreatment group is obviously higher than that of the control group.
Although the invention has been described in detail hereinabove with respect to a general description and specific embodiments thereof, it will be apparent to those skilled in the art that modifications or improvements may be made thereto based on the invention. Accordingly, such modifications and improvements are intended to be within the scope of the invention as claimed.
Claims (9)
1. Application of insulin-like growth factor 2 in promoting differentiation of human skin fibroblasts into adipocytes.
2. Use according to claim 1, characterized in that human skin fibroblasts are pretreated with insulin-like growth factor 2 at a final concentration of 50-200ng/ml before being subjected to induced differentiation in vitro.
3. A method for inducing human skin fibroblasts to differentiate into adipocytes in vitro is characterized in that the human skin fibroblasts are cultured in vitro in a basal culture medium, insulin-like growth factor 2 with the final concentration of 50-200ng/ml is added when the confluence degree of the cells reaches 50-70%, the cells are pretreated for 12-48 hours, and then induced differentiation is carried out;
the step of inducing differentiation comprises: changing the culture medium into an induced differentiation culture medium I, culturing for 6-10 days, and changing the culture medium every two days; then, replacing the induced differentiation culture medium I with an induced differentiation culture medium II, and culturing for 2-4 days; finally, changing the induced differentiation culture medium to a basic culture medium, culturing for 8-14 days, and changing the culture medium once every two days;
wherein the basic culture medium is a high-glucose DMEM culture medium containing 10-20% fetal calf serum, 100U/mL penicillin and 100 mu g/mL streptomycin;
the induced differentiation culture medium I is a basic culture medium containing 0.5-1 mu M dexamethasone, 10-20 mu g/mL insulin, 1-2 mu M rosiglitazone and 0.2-0.5mM 1-methyl-3-isobutyl xanthine;
the induction differentiation culture medium (II) is a basal culture medium containing 10-20 mug/mL of insulin.
4. The method according to claim 3, wherein the differentiation induction medium (r) is a basal medium containing 1 μ M dexamethasone, 20 μ g/mL insulin, 2 μ M rosiglitazone and 0.5mM 1-methyl-3-isobutylxanthine.
5. The method of claim 3, wherein the differentiation-inducing medium (c) is a basal medium containing 20 μ g/mL of insulin.
6. The method of claim 3, wherein insulin-like growth factor 2 is present at a final concentration of 50ng/ml, 100ng/ml or 200 ng/ml.
7. The method according to claim 3, characterized in that human skin fibroblasts are cultured in vitro in a basal medium and passed within 10 passages, after the confluence of the cells reaches 50-70%, insulin-like growth factor 2 is added to the cells at a final concentration of 50-200ng/ml, and the cells are pretreated for 24 hours; then, the culture medium is changed into an induced differentiation culture medium I, and the culture is carried out for 6 days, and the liquid is changed every two days; then, the induced differentiation medium I is replaced by an induced differentiation medium II, and the culture is carried out for 2 days; finally, changing the induced differentiation culture medium to a basic culture medium, culturing for 8 days, and changing the culture medium once every two days;
wherein the basic culture medium is a high-glucose DMEM culture medium containing 20% fetal calf serum, 100U/mL penicillin and 100 mu g/mL streptomycin;
the induced differentiation culture medium I is a basic culture medium containing 1 mu M dexamethasone, 20 mu g/mL insulin, 2 mu M rosiglitazone and 0.5mM 1-methyl-3-isobutyl xanthine;
the induction differentiation culture medium is a basal culture medium containing 20 mu g/mL insulin.
8. The method of any one of claims 3 to 7, wherein the cell culture conditions are: 35-37 ℃ and 5% CO2。
9. The method of claim 8, wherein the cell culture conditions are: 37 ℃ and 5% CO2。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010266819.8A CN111518753B (en) | 2020-04-07 | 2020-04-07 | Application of insulin-like growth factor 2 in promoting differentiation of human skin fibroblasts into adipocytes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010266819.8A CN111518753B (en) | 2020-04-07 | 2020-04-07 | Application of insulin-like growth factor 2 in promoting differentiation of human skin fibroblasts into adipocytes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111518753A true CN111518753A (en) | 2020-08-11 |
| CN111518753B CN111518753B (en) | 2021-12-10 |
Family
ID=71901715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010266819.8A Active CN111518753B (en) | 2020-04-07 | 2020-04-07 | Application of insulin-like growth factor 2 in promoting differentiation of human skin fibroblasts into adipocytes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111518753B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113151161A (en) * | 2021-04-23 | 2021-07-23 | 北京大学 | Application of insulin-like growth factor 2 in promoting differentiation of cancer cells into adipocytes |
| CN113174368A (en) * | 2021-04-21 | 2021-07-27 | 北京大学 | Application of bone morphogenetic protein in promoting differentiation of human skin fibroblasts into adipocytes |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108350423A (en) * | 2015-07-10 | 2018-07-31 | 法国血液机构 | Method for obtaining mankind's brown/cream-coloured adipocyte |
| US20190203177A1 (en) * | 2016-06-24 | 2019-07-04 | The Brigham And Women`S Hospital, Inc. | Generation of Brown Adipose Tissue from Pluripotent Stem Cells in Vitro |
| CN110592003A (en) * | 2019-09-17 | 2019-12-20 | 北京大学 | Method for inducing human skin fibroblast to differentiate into fat cell in vitro |
-
2020
- 2020-04-07 CN CN202010266819.8A patent/CN111518753B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108350423A (en) * | 2015-07-10 | 2018-07-31 | 法国血液机构 | Method for obtaining mankind's brown/cream-coloured adipocyte |
| US20180216070A1 (en) * | 2015-07-10 | 2018-08-02 | Etablissement Francais Du Sang | Method for obtaining human brown/beige adipocytes |
| US20190203177A1 (en) * | 2016-06-24 | 2019-07-04 | The Brigham And Women`S Hospital, Inc. | Generation of Brown Adipose Tissue from Pluripotent Stem Cells in Vitro |
| CN110592003A (en) * | 2019-09-17 | 2019-12-20 | 北京大学 | Method for inducing human skin fibroblast to differentiate into fat cell in vitro |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113174368A (en) * | 2021-04-21 | 2021-07-27 | 北京大学 | Application of bone morphogenetic protein in promoting differentiation of human skin fibroblasts into adipocytes |
| CN113151161A (en) * | 2021-04-23 | 2021-07-23 | 北京大学 | Application of insulin-like growth factor 2 in promoting differentiation of cancer cells into adipocytes |
| CN113151161B (en) * | 2021-04-23 | 2023-02-17 | 北京大学 | Application of insulin-like growth factor 2 in promoting differentiation of cancer cells into adipocytes |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111518753B (en) | 2021-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110592003B (en) | Method for inducing human skin fibroblast to differentiate into fat cell in vitro | |
| CN111518753B (en) | Application of insulin-like growth factor 2 in promoting differentiation of human skin fibroblasts into adipocytes | |
| Yang et al. | The influence of rat mesenchymal stem cell CD44 surface markers on cell growth, fibronectin expression, and cardiomyogenic differentiation on silk fibroin–hyaluronic acid cardiac patches | |
| RU2331668C2 (en) | Stromal cells, obtained from adipose tissue, and their applying for cornea defects and intraocular defects healing | |
| Li et al. | Human umbilical cord blood-derived mesenchymal stem cells contribute to chondrogenesis in coculture with chondrocytes | |
| Kang et al. | In vitro and in vivo osteogenesis of porcine skin-derived mesenchymal stem cell–like cells with a demineralized bone and fibrin glue scaffold | |
| US11339372B2 (en) | Serum-free medium inducing differentiation of umbilical cord mesenchymal stem cell into insulin-secretion-like cell and preparation method and use thereof | |
| KR20100065338A (en) | Method for extracting mesenchymal stem cell from human or animal embryo and for extracting the secretion product thereof | |
| CN109837239B (en) | Primary culture and serum-free multidirectional induced differentiation method for human adipose-derived stem cells | |
| EP3019599B1 (en) | Method for isolating stromal vascular fraction | |
| Stacey et al. | In vitro adipogenic differentiation of preadipocytes varies with differentiation stimulus, culture dimensionality, and scaffold composition | |
| Xiong et al. | Retention of the stemness of mouse adipose-derived stem cells by their expansion on human bone marrow stromal cell-derived extracellular matrix | |
| US20140271616A1 (en) | Compositions And Methods For Mesenchymal And/Or Chondrogenic Differentiation Of Stem Cells | |
| CN111518752B (en) | Application of vitamin D3 and analogues thereof in promoting differentiation of human skin fibroblasts into adipocytes | |
| CN111826343A (en) | Cell culture solution for enhancing induced cartilage differentiation, method and application | |
| CN111925985B (en) | Domestication culture method of mesenchymal stem cells | |
| CN106318979B (en) | Method for inducing transdifferentiation of mesenchymal stem cells into skin stem cells | |
| CN111254110A (en) | Method for transdifferentiation of mesenchymal stem cells into sperms | |
| CN114480261B (en) | Extraction and separation method of umbilical cord source bone stem cells | |
| CN114939123A (en) | Therapeutic preparation for promoting wound repair | |
| CN110484491B (en) | Method for obtaining amniotic membrane and amniotic fluid derived endothelial progenitor cells and purification culture method thereof | |
| CN113174368A (en) | Application of bone morphogenetic protein in promoting differentiation of human skin fibroblasts into adipocytes | |
| US20150147409A1 (en) | Adipose stromal vascular fraction-conditioned medium | |
| CN113249307B (en) | Application of vitamin D3 and analogue thereof in promoting cancer cells to differentiate into fat cells | |
| CN113151161B (en) | Application of insulin-like growth factor 2 in promoting differentiation of cancer cells into adipocytes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |